BIOELECTRIC CUSTOMIZED
INFLAMMATION CONTROL

InStim’s patent pending technology is the
world’s first designed to read
inflammation real time and constantly adjust
bioelectric stimulation and cytokine
releases to modulate and manage
inflammation real time.
LEARN MORE

InStim – Patent Pending Technology

InStim’s patent pending technology is the world’s first designed to read inflammation real time and constantly adjust bioelectric stimulation and cytokine releases to modulate and manage inflammation real time. We believe this is the only way to properly break the cycle of chronic inflammation.

We believe we can hit a re-start button on a person’s chronic inflammation cycle!

Our microprocessor stores ideal optimal healing cycles and the treatment regimes are adjusted real time between data coming in via real-time monitoring of inflammation and ideal optimal healing algorithms stored in our microprocessor of our micro stimulator + reader. The ideal optimal healing cycles are derived from measurements made in healthy subjects that have an inflammation-causing event and recover quickly and fully (such as a toddler head injury recovery).

Patent Pending Leonhardt Bioelectric Inflammation Management
We believe proper inflammation management is served best by bioelectric energy management that in turn controls release of the right cytokines in the right sequence at the right time for healthy recovery, especially when combined with proper diet and exercise.
About InStim: InStim is an early stage startup incubating in the Leonhardt’s Launchpads innovation accelerators in Santa Monica and Playa Vista, California focused on customized inflammation management with bioelectric stimulation. Leonhardt’s Launchpads Utah, Inc. is also participating in advancing this technology platform forward at our research lab in Utah @ BioInnovations Gateway. InStim is licensing its technology to other startups within Leonhardt’s Launchpads accelerators for specific organ applications such as CerebraCell for brain injury recovery, PancreaCell for pancreas regeneration recovery from pancreatitis, CancerCell for bioelectric cancer treatments and BioLeonhardt for chronic heart failure recovery.

Get in touch.

  • This field is for validation purposes and should be left unchanged.

CAUTION Disclaimer and Warning: Products described on this web site are in early stage development and are not yet proven safe or effective in statistically significant controlled clinical studies. Any statement or phrases implying efficacy or safety in any form are considered modified by “intended to” or “designed to”. Investigational use only in countries where investigation is permitted by law and proper filings have been made and appropriate regulatory clearances have been granted. Any use of the product(s) must be in an authorized clinical study with institutional review board (ethics committee) approval and proper patient consent procedures followed. For other countries product is only available for laboratory investigation by credentialed institutions and investigators with proper clearances with a research agreement in place with a study sponsor. NOT AVAILABLE FOR SALE.